FDA Adverse Event Injury Summary report: N

TRIATHLON PRIM TIB BASEPLATE - CEMENTED

MDR report key: 2155494 · Received June 30, 2011

Report

Report Number
2249697-2011-00981
Event Type
Injury
Date Received
June 30, 2011
Date of Event
January 5, 2010
Report Date
June 7, 2011
Manufacturer
STRYKER ORTHOPAEDICS MAHWAH
Product Code
JWH
PMA / PMN Number
K040267
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE FOLLOWING OTHER KNEE DEVICES WERE ALSO LISTED IN THIS REPORT: TRIATHLON-CR FEMORAL COMPONENTCEMENTED #4 LEFT; CAT# 5510-F-401; LOT SPENB. X3 TRIATHLON CS INS SIZE4 11MM; CAT# 5531-G-411; LOT LBS690. TRIATHLON ASYMMETRIC X3 PATELLA; CAT# 5551-G-350; LOT 909A. SIMPLEX P - US TOBRA FD 10-PK; CAT# 6197-9-010; LOT# MLP062. IT CANNOT BE DETERMINED WHICH, IF ANY OF THESE DEVICES MAY HAVE CAUSED OR CONTRIBUTED TO THE PATIENT'S PAIN. AN EVALUATION OF THE DEVICE(S) CANNOT BE PERFORMED AS THE DEVICE(S) REMAINED IMPLANTED IN THE PATIENT WAS NOT RETURNED TO THE MANUFACTURER. ADDITIONAL INFORMATION (INCLUDING X-RAYS AND MEDICAL RECORDS) HAS BEEN RECEIVED. A SUPPLEMENTAL REPORT WILL BE SUBMITTED UPON COMPLETION OF THE INVESTIGATION.

Description of Event or Problem · 1

IT WAS REPORTED THAT, "PATIENT WAS GIVING HER KNEE REPLACEMENT TIME TO HEAL BUT CONTINUED TO EXPERIENCE SEVERE PAIN. THE SURGEON X-RAYED THE KNEE IN (B)(6) 2010 AND SAID SHE NEEDED MORE RECOVERY TIME. ONE YEAR AFTER THE INITIAL SURGERY, THE PATIENT IS STILL EXPERIENCING EXTREME PAIN. THE PATIENT RETURNED TO HER SURGEON WHO WAS UNCOOPERATIVE AND THE PATIENT WENT FOR A SECOND OPINION APPROXIMATELY (B)(6) OF 2011. X-RAYS AND MRI WERE DONE DURING THAT TIME AND THE NEW SURGEON, DOCTOR (B)(6) STATED THAT SHE NEEDS A REVISION SURGERY WHICH IS SCHEDULED (B)(6), 2011."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TRIATHLON PRIM TIB BASEPLATE - CEMENTED IMPLANT JWH STRYKER ORTHOPAEDICS MAHWAH NA AJUG

Patients

Seq Age Sex Outcome Treatment
1 65 YR Other